The gene and cell therapy group Oxford Biomedica plc has appointed Roch Doliveux as non-executive chairman. Dr Doliveux was previously chief executive of UCB SA. He is currently chairman of the board of the French pharmaceutical and cosmetics company Pierre Fabre SA, as well as non-executive director at Stryker Corp Inc and UCB. Dr Doliveux trained as a veterinary surgeon, and has an MBA from INSEAD in France.
Oxford Biomedica plc announced the appointment on 1 June 2020.
Copyright 2020 Evernow Publishing Ltd